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Abstract: Introduction: We evaluated the effectiveness of an individual, group and community
intervention to improve the glycemic control of patients with diabetes mellitus aged 45–75 years
with two or three unhealthy life habits. As secondary endpoints, we evaluated the inverventions’
effectiveness on adhering to Mediterranean diet, physical activity, sedentary lifestyle, smoking
and quality of life. Method: A randomized clinical cluster (health centers) trial with two parallel
groups in Spain from January 2016 to December 2019 was used. Patients with diabetes mellitus
aged 45–75 years with two unhealthy life habits or more (smoking, not adhering to Mediterranean
diet or little physical activity) participated. Centers were randomly assigned. The sample size was
estimated to be 420 people for the main outcome variable. Educational intervention was done to
improve adherence to Mediterranean diet, physical activity and smoking cessation by individual,
group and community interventions for 12 months. Controls received the usual health care. The
outcome variables were: HbA1c (main), the Mediterranean diet adherence score (MEDAS), the
international diet quality index (DQI-I), the international physical activity questionnaire (IPAQ),
sedentary lifestyle, smoking ≥1 cigarette/day and the EuroQuol questionnaire (EVA-EuroQol5D5L).
Results: In total, 13 control centers (n = 356) and 12 intervention centers (n = 338) were included
with similar baseline conditions. An analysis for intention-to-treat was done by applying multilevel
mixed models fitted by basal values and the health center: the HbA1c adjusted mean difference
= −0.09 (95% CI: −0.29–0.10), the DQI-I adjusted mean difference = 0.25 (95% CI: −0.32–0.82),
the MEDAS adjusted mean difference = 0.45 (95% CI: 0.01–0.89), moderate/high physical activity
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OR = 1.09 (95% CI: 0.64–1.86), not living a sedentary lifestyle OR = 0.97 (95% CI: 0.55–1.73), no
smoking OR = 0.61 (95% CI: 0.54–1.06), EVA adjusted mean difference = −1.26 (95% CI: −4.98–2.45).
Conclusions: No statistically significant changes were found for either glycemic control or physical
activity, sedentary lifestyle, smoking and quality of life. The multicomponent individual, group
and community interventions only showed a statistically significant improvement in adhering
to Mediterranean diet. Such innovative interventions need further research to demonstrate their
effectiveness in patients with poor glycemic control.
Keywords: health promotion; diabetes mellitus; exercise; Mediterranean diet; tobacco use disorder;
primary health care
1. Introduction
Diabetes mellitus (DM) is a world public health problem that affects 60 million people
in Europe. Different health care organizations face this disease, which has a strong added
socioeconomic impact [1]. This challenge not only centers on caring for DM itself, but also
on its associated complications, with increasingly higher morbidity-mortality rates [2].
Healthy life habits directly influence glycemic control, which is why they are related to
DM diagnosis, treatment and prognosis [1,2]. Every percentage of lowering HbA1c means
43% less peripheral artery disease, 37% fewer microvascular complications, 21% lower
DM-related mortality, 14% fewer cardiac infarctions and 12% fewer strokes [3]. Handling
this complex disease also affects people’s quality of life, and DM patients’ quality of life
tends to be worse than for people without chronic diseases [4]. Finally, the worse their
quality of life, the more difficult it is to control HbA1c [5].
Most adults present several unhealthy life habits that are interrelated [6]. Galán et al. [7]
state that 20% of the Spanish population adopts three or four unhealthy life habits, and
smoking is the factor that mostly frequently interrelates to the others.
The Spanish population smokes more than average in the European Union [8] despite
smokers and passive smokers being at higher risk of cardiovascular disease, premature
death and microvascular complications [9,10]. In type 2 DM, smoking cessation entails
significant benefits to help HbA1c to lower [11].
Physical exercise considerably improves HbA1c regardless of weight loss [12,13].
Recent studies have related living a sedentary lifestyle to a higher risk of premature death
independently of the level of physical activity practiced [14]. In DM, avoiding a sedentary
lifestyle also helps glycemic control [15].
Eating a Mediterranean diet substantially lowers HbA1c, delays having to take antidi-
abetics and reduces cardiovascular events and overall mortality [16–18]. Given the Spanish
population’s Mediterranean nature, food recommendations must be supported by this diet
pattern [19].
As primary care (PC) interventions to change unhealthy life habits have increased in
recent years, studies to evaluate their effectiveness are needed [6,20]. In practice, the most
widespread strategy to bring about change in conduct is to advise about a single unhealthy
habit or risk factor [21]. Nevertheless, this approach type has a weaker impact on people’s
health compared to interventions that address several unhealthy life habits (multi-risk
approach) [22]. Another question lies in the way these life habits are dealt with and,
although individual and group approaches are effective, they are normally implemented
separately [23,24].
The combination of several components in a single intervention is what defines “mul-
ticomponent interventions” [25]. Research into the effectiveness of such interventions is
ample and varied and has analyzed several approaches according to the type of inter-
vention and methodology used to promote health. With DM, these kind of interventions
performed to date are not backed by solid evidence for simultaneously dealing with
different unhealthy life habits [26,27].
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Therefore, the multicomponent intervention in the present study was conducted in
PC by focusing on diet, physical activity and smoking to include individual, group and
community components. These three types of approaches are essentials in any organized
diabetes-based education program to suitably achieve disease self-management [1].
In 2012, the Research Network in Preventive and Health Promotion Activities (redI-
APP) [28] started designing a multicomponent intervention in Spain for people aged
45–75 years to promote healthy life habits to improve quality of life and avoid high-
prevalence chronic diseases. This project was called EIRA. To date, the results of the
first three phases (preclinical, I and II) have been published [29–32]. This article presents
the results of the patients with DM included in the EIRA trial [33]. A hypothesis was
posed: the multicomponent intervention would find statistically significant differences in
the glycemic control of DM patients with several unhealthy life habits compared to those
receiving the usual PC.
The main objective of this study was to assess the effectiveness of a multicomponent
intervention in the glycemic control of patients with DM aged 45–75 years with two un-
healthy life habits or more (smokers, not practicing enough physical activity and/or barely
adhering to Mediterranean diet). Its secondary objective was to assess the effectiveness of
this intervention in adhering to Mediterranean diet, physical activity, sedentary lifestyle,
smoking and quality of life.
2. Materials and Methods
2.1. Design
A randomized clinical cluster (primary health care centers) trial with a control group
was used. This randomized clinical trial (RCT) is known as the EIRA trial, which is
registered at ClinicalTrials.gov with number “NCT03136211”.
The article presents the results of an analysis performed with all the patients diagnosed
with DM who were included in the EIRA trial [33]. Consolidated Standards of Reporting
Trials (CONSORT) recommendations were followed to present the results [34]. A cluster-
randomized clinical trial (RCT) conducted with the subgroup of patients with DM was
included in EIRA project phase 3 [19]. The trial registration number is NCT03136211.
CONSORT recommendations were followed to present the results [20].
2.2. Study Area
This RCT was performed in 26 primary health care centers (PHCCs) in 7 health depart-
ments in Spain from January 2016 to December 2019. Spain’s national health system (NHS)
guarantees health services in each Spanish territory/Spanish autonomous community by
means of health departments. Health care is organized at two levels: PC and hospital
care. PHCCs are made up of a multidisciplinary team with doctors, nurses, pediatricians,
midwives, social workers, pharmacists and dentists who perform health care services,
health education, health promotion/prevention and community activities.
2.3. Inclusion and Exclusion Criteria
PHCCs: The selected centers had to meet these criteria: not be located in areas with
much sociocultural diversity or in areas with considerable tourism, have access to the
internet, offer the possibility of prescribing community activities, recommend community
activities and have professionals available who are particularly committed to this study.
Professionals’ participation was voluntary.
Patients: The DM patients from the EIRA trial aged 45–75 years with two unhealthy
life habits or more (smoking, nor adhering to Mediterranean diet or not practicing much
physical activity) were included. The exclusion criteria were as follows: have a serious
illness, cognitive impairment or severe mental illness, not dependently able to perform
basic activities of daily living, participating in a long-term home health care program, being
treated for cancer or receiving end-of-life care. Those patients who did not plan to reside in
the area while the intervention lasted were also excluded [33].
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DM patients included anyone who met any of the following criteria [35]: having a
registered medical background of DM being diagnosed when the intervention started or
ended, presenting HbA1c ≥6.5% in the 6 months before the intervention began and being
prescribed any antidiabetic when the intervention began.
2.4. Intervention (EIRA Study)
An educational intervention to promote health about Mediterranean food, physical
activity and smoking lasted 12 months, took place in PHCCs and was personally adminis-
tered by patients’ doctors and nurses.
The professionals who participated in this intervention were trained for more than
60 h to standardize the intervention.
The EIRA intervention consisted in a multicomponent approach for each life habit, at
three levels (individual, group and community) according to each patient’s conduct change
stage [36]. The individual intervention consisted in a short educational intervention during
consultations and sending reminder text messages. Those people in the contemplative and
preparation phase could also employ a mobile application to perform continuous activity
toward their physical activity and diet. Group interventions consisted in organizing
a workshop and focused only on physical activity and diet. Finally, the community
intervention included recommending community resources to help to improve adhering to
the Mediterranean diet and increasing physical activity (social prescription) [33].
While the intervention was underway, health care professionals attempted to adapt the
different intervention components to each patient’s characteristics (resources, expectations,
requirements, etc.). During the first visit, professionals agreed with patients on a specific
approach and follow-up plan.
The individual intervention included 2–3 visits and the possibility of further rein-
forcing the intervention. Depending on the change phase each patient was in regarding
their life habits, the following took place: (1) “a very brief intervention” with the objective
to raise more awareness of the need to change life habits and support any changes or
help to prevent possible relapses; (2) “a brief intervention” to establish a specific agreed
plan to change behavior. Health care professionals performed this brief intervention by
applying motivational techniques after they received 20 h of online training [37]. This
intervention type was supported by an informative website, sending personalized texts
and using mobile applications or other electronic devices (pedometers, smart watches, etc.).
At the end of consultations, the professionals involved in all the individual interventions
handed out to each patient the written support material as a reinforcement mechanism.
The brief intervention for Mediterranean diet included personalized recommendations
about the changes that each patient had to include to help them adhere to this diet pattern
according to the therapeutic objectives set out. This food pattern is generally characterized
by eating plenty of plant food like fruit and vegetables, legumes, dried fruit and nuts,
cereals and rice. In the diet included in the intervention, olive oil was the main source of fat.
Moderate amounts of fish, seafood, poultry, dairy products and eggs were included. Small
portions of red meat and a very small daily amount of wine with meals were indicated [19].
The brief intervention to deal with smoking included setting day D to stop smoking,
offering pharmacological/conduct treatment, and follow-up visits after 7–15 days and
1 month after smoking cessation.
The brief intervention for physical activity was based on the health care professionals
reaching a consensus with patients, an individualized physical activity plan including
community resources or specific programmers to be done in PHCCs to increase the chances
of performing physical activity.
The group intervention took place during a health education workshop, and focused
on healthy diet and physical activity. It aimed to reinforce the recommendations made
in the individual intervention, and to provide patterns that helped to adhere to Mediter-
ranean diet and practice physical exercise. This workshop began after the first individual
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intervention visit. It included two sessions lasting 90–120 min each, performed by the
health care professionals from PHCCs.
The community intervention consisted of recommending social activities [38] in the
patient’s own neighborhood according to the detected risky life habits and accessibility
to community resources, e.g., gyms, allotments, healthy walking, etc. The professionals
from PHCCs previously identified the community’s health assets [39] and selected the
most appropriate ones according to the detected unhealthy behaviors, accessibility and the
possibility of referring participants.
All the details of interventions are specified in the study protocol [33]. No blinding
was included in relation to either the patients in the two study groups or the health care
professionals who undertook the IRA intervention.
2.5. Usual Health Care (the PHCC Control Group)
The participants from the PHCC control group received usual health care in accordance
with the national recommendations and guidance. If a change in life habits was necessary,
it was recommended when DM patients went to consultations with their family doctors or
nurses, where they received some brief advice [40,41].
2.6. Measures and Data Collection
The main outcome variable was HbA1c (%). The secondary outcome variables
included adhering to Mediterranean diet (MEDAS) [42], adhering well to the Mediter-
ranean diet (MEDAS ≥9), diet quality (DQI-I) [43], physical activity (IPAQ per category:
low < 600 MET/moderate-high) [44], sedentary lifestyle (sat down ≥6 h/day) [45], smok-
ing (≥1 cigarette/day) and quality of life (the VAS scale of EuroQol-5D5L) [46].
In order to evaluate the effectiveness of the EIRA intervention, the initial (0 months)
and final (12 months) data of the outcome variables were compared. This information was
collected in PHCCs by means of an external support unit to not increase the work overload
of these professionals involved in the intervention. These professionals received specific
training in the measuring instruments and about the electronic data collection notebook,
which was designed ad hoc by a group of experts from redIAPP [28].
Supplementary Material File S1 offers details about the independent variables.
2.7. Sample Size
In order to calculate the EIRA trial sample size, a ≥8% difference was taken of those
people showing a positive change in one life habit or more of the three life habits between
both study groups [33]. Moreover, 30% of losses through follow-up, a 5% alpha risk, a
20% beta risk and a 0.01 intragroup correlation were taken [47]. According to these data, a
minimum of 140 participants were considered for each PHCC, with 3640 people in all and
1820 in each study group (control and intervention). The PASS software was employed to
calculate the sample size. For the present study, all the DM patients present in the final
EIRA trial sample were selected.
In parallel, the DM sample needed to detect a minimum 0.3% reduction in the HbA1c
value in these patients after the intervention was estimated [48–50], and it was necessary
to study at least 420 people. Calculations were done using the Gpower freeware by
considering the calculated sample size for the EIRA trial (3640).
2.8. Randomization
The randomization unit was PHCCs. This process was centralized on the University
Institute Foundation for Research in Primary Health Care Jordi Gol, Barcelona (Spain) using
the statistical R software. For the seven participating Spanish autonomous communities
(SAC), half the PHCCs were randomly assigned to the control group (CG) and the other
half to the intervention group (IG). This gave 13 PHCCs in the CF and 13 others in the IG.
Both the patients and professionals knew which group they had been assigned to.
Figure 1 depicts the study’s flow diagram.
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2.9. Recruitment
Population selection was performed opportunistically between February 2017 and Jan-
uary 2018 and was stratified by the age/gender distribution expected from the
participating PHCCs.
The doctors and nurses from PHCCs performed population recruitment by the dif-
ferent methods set out in the study protocol [33]: (1) during the visits that form part of
usual health care, (2) self-administered questionnaires handed out in waiting rooms or at
admission desks, (3) advertising on posters inside PHCCs and (4) telephoning the selected
patients by revising electronic medical records.
The professionals were previously trained to ensure a homogenous procedure.
2.10. Statistical Analysis
The statistical analysis was performed with packages lme4 [51] and mice [52] of the R
freeware [53] and SPSS v19 was also used [54].
Following the CONSORT recommendations for non-pharmacological interventions [34],
and to reduce any bias due to lack of data during the follow-up, an intention-to-treat (ITT)
analysis was carried out.
After sorting and analyzing the quality of the obtained data, multiple imputation
was performed by random forest to avoid the collinearity influence [55]. Lost values were
assumed to be values missing at random [56]. The following were included: intervention
(yes/no), PHCCs, all the initial/final outcome variables, stratification variables (age, gen-
der) and auxiliary variables with losses below 30% and the possible influence on outcome
(comorbidities, motivation, clinical variables). The imputation phase created many copies
of datasets, and each one contained different estimations of missed values. Then, the
imputed datasets were analyzed.
In order to check the changes observed from the beginning to the end of the study in
each group and for every outcome variable (primary and secondary), mixed multilevel
effects were regressed (linear for continuous results, logistic for dichotomic results). Each
model included the basal values of the outcome variables because they were repeated
measures. In practice, such a high correlation like 0.7 is quite feasible for the same variable
measured at the baseline after processing, and the fit of this baseline is most important [57].
This value and the intervention were taken as fixed effects and PHCCs as random effects.
All this was performed using the lme4 package [51], which identifies the model’s parameters
that optimize the restricted maximum likelihood criterion.
This was how a set of estimations of parameters and standard errors was obtained,
which were combined according to the guidance of Rubin [56]. As a result of the combi-
nation, the adjusted difference in the means between groups for the continuous results
and the odds ratio (OR) for the dichotomic outcome variables were calculated with 95%
confidence intervals (95% CI) in both situations.
Then, the regression analysis of the multilevel mixed effects was repeated with the com-
plete cases for all the outcome variables in a similar manner to that previously described.
A descriptive study was done of the variables included in both the CG and IG. The
quantitative variables were expressed with their absolute value (N), mean and standard
deviation (SD) or median (med.) and the interquartile range (IQR). The qualitative variables
were expressed with their absolute value, percentage (%) and 95% CI. To make the basal
comparison, the following were used in each particular case: the Chi-squared test or
Fisher’s exact test for the qualitative variables; the Mann–Whitney U or Student’s t-test for
the quantitative variables.
Statistical significance (p) was evaluated at the <0.05 level (two-tail).
3. Results
Of our study population, 96% were recruited between March and September 2017, and
the rest until January 2018, and 90% of the patients were opportunistically recruited during
their visits to their PC doctors or nurses. The remaining 10% were recruited by telephone
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using each professional’s list of patients, and by self-administered questionnaires that were
voluntarily completed as they were available in PHCCs.
Figure 2 shows how one PHCC of the IG left the study for reasons beyond our control
before the EIRA intervention began. This left 13 PHCCs for the CG and 12 for the IG.
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We included 3062 patients, of whom 694 had DM (22.66% (95% CI: 21.22–24.18)) with
356 in the CG and 338 in the IG (p = 0.312): overall, 277 patients in the CG and 263 in the GI
finished the study (Table 1). The PHCCs’ characteristics are provided in File S2 Table S1.
The follow-up protocol is presented in File S2 Table S2.
The basal descriptive analysis of the study variables was published in the Revista
Española de Salud Pública [58] and can be consulted in File S3.
According to Table 1, 62.36% (95% CI: 57.24–67.28) of the CG and 62.13% (95% CI:
56.87–67.18) of the IG were male, and the median of their age was 60 years for both groups
with an IQR of 54–66 and 54–67, respectively. The analysis of the basal values showed no
differences between both groups in most variables [58].
Table 2 presents the post-EIRA intervention descriptive analysis of the outcome variables.
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Table 1. Baseline characteristics of the patients with diabetes mellitus.
Variables
Control (n = 356) Intervention (n = 338)
p
n med. (IQR)/%(95% CI) * n
med. (IQR)/%
(95% CI) *)
Age 356 60.00 (54.00–66.00) 338 60.00 (54.00–67.00) 0.901
Gender * 356 338 1.000
Male 222 62.36 (57.24–67.28) 210 62.13 (56.87–67.18)
Female 134 37.64 (32.72–42.76) 128 37.87 (32.82–43.13)
Civil status * 354 335 0.296
Single 48 13.56 (10.29–17.42) 31 9.25 (6.50–12.71)
Married/Live with a partner 244 68.93 (63.97–73.58) 238 71.04 (66.02–75.71)
Separated and/or divorced 36 10.17 (7.35–13.64) 43 12.84 (9.58–16.73)
Widow/Widower 25 7.06 (4.74–10.08) 23 6.87 (4.52–9.95)
Other 1 0.28 (0.03–1.31) 0 0.00 (0.00–0.00)
Country born in * 355 335 0.420
Spain 326 91.83 (88.64–94.34) 318 94.93 (92.18–96.90)
Rest of Europe 8 2.25 (1.07–4.21) 5 1.49 (0.57–3.24)
America 17 4.79 (2.92–7.39) 9 2.69 (1.34–4.85)
Asia 0 0.00 (0.00–0.00) 0 0.00 (0.00–0.00)
Africa 4 1.13 (0.38–2.66) 3 0.90 (0.25–2.37)
Spanish Autonomous Community * 356 338 0.000
Andalusia 52 14.61 (11.23–18.56) 48 14.20 (10.79–18.22)
Aragón 29 8.15 (5.64–11.33) 56 16.57 (12.90–20.81)
Balearics 79 22.19 (18.11–26.72) 72 21.30 (17.19–25.90)
Castilla y León 33 9.27 (6.59–12.61) 49 14.50 (11.05–18.55)
Catalonia 49 13.76 (10.48–17.63) 43 12.72 (9.49–16.59)
Galicia 59 16.57 (12.99–20.70) 46 13.61 (10.27–17.57)
Basque Country 55 15.45 (11.98–19.48) 24 7.10 (4.71–10.21)
Level of education * 353 335 0.882
Higher Education 42 11.90 (8.83–15.58) 39 11.64 (8.54–15.40)
Secondary Education 123 34.84 (30.01–39.92) 118 35.22 (30.25–40.45)
Primary Education 157 44.48 (39.35–49.69) 154 45.97 (40.69–51.32)
No studies 31 8.78 (6.16–12.07) 24 7.16 (4.77–10.30)
Occupation * 355 335 0.746
Student 0 0.00 (0.00–0.00) 1 0.30 (0.03–1.39)
Employee 91 25.63 (21.30–30.36) 83 24.78 (20.38–29.60)
Self-employed 37 10.42 (7.57–13.92) 34 10.15 (7.26–13.72)
Leave from work >3 months 8 2.25 (1.07–4.21) 11 3.28 (1.76–5.61)
Unemployed and paid 24 6.76 (4.49–9.73) 14 4.18 (2.41–6.73)
Unemployed not paid 14 3.94 (2.28–6.35) 14 4.18 (2.41–6.73)
Household tasks 37 10.42 (7.57–13.92) 41 12.24 (9.06–16.07)
Permanent disability 17 4.79 (2.92–7.39) 12 3.58 (1.97–5.99)
Retired 127 35.77 (30.92–40.86) 125 37.31 (32.26–42.58)
Glycemic control
HbA1c (%) 279 6.80 (6.30–7.90) 253 6.90 (6.40–7.70) 0.884
Regular/good control (HbA1c <8%) (Yes) * 215 77.06 (71.87–81.70) 205 81.03 (75.86–85.49) 0.322
Mediterranean diet
Adhering to Mediterranean diet (MEDAS) 354 7.00 (5.00–8.00) 338 7.00 (5.00–8.00) 0.828
Good adherence (MEDAS ≥9) (Yes) * 73 20.62 (16.66–25.06) 55 16.27 (12.63–20.49) 0.238
Diet quality (DQI-I) 354 38.00 (36.00–41.00) 335 38.00 (36.00–40.00) 0.576
Physical activity
Little physical activity (IPAQ) 353 328 0.818
Moderate/Intensive * 168 47.59 (42.42–52.80) 153 46.65 (41.30–52.05)
Low (<600 MET.min/week) * 185 52.41 (47.20–57.58) 175 53.35 (47.95–58.70)
Sedentary lifestyle (≥6 h/week sat down) (Yes) * 111 42.05 (36.20–48.06) 98 38.13 (32.35–44.18) 0.373
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Table 1. Cont.
Variables
Control (n = 356) Intervention (n = 338)
p




≥1 cigarette/day (Yes) * 145 40.73 (35.72–45.89) 127 37.57 (32.53–42.83) 0.437
Quality of life
VAS (EuroQol-5D5L) 348 70.00 (50.00–80.00) 335 70.00 (50.00–80.00) 0.676
n: absolute value; med.: median; IQR: interquartile range; %: percentage; CI: confidence interval; HbA1c: glycosylated hemoglobin; MEDAS:
Mediterranean diet adherence questionnaire; DQI-I: international diet quality index; IPAQ: international physical activity questionnaire;
VAS: visual analogue scale of the EuroQol-5D5L quality of life questionnaire; P: statistical significance. * expressed as % (95% CI).
Table 2. Descriptive postintervention analysis of the outcome variables.
Variables
Control (n = 356) Intervention (n = 338)
n med. (IQR)/% (95% CI) * n med. (IQR)/% (95% CI) *
Glycemic control
HbA1c (%) 188 6.80 (6.30–7.70) 169 6.70 (6.20–7.40)
Regular/good control (HbA1c <8%) (Yes) * 153 81.38 (75.36–86.45) 152 89.94 (84.73–93.80)
Mediterranean diet
Adhering to Mediterranean diet (MEDAS) 268 8.00 (6.00–9.00) 262 8.00 (7.00–9.00)
Good adherence (MEDAS ≥9) (Yes) * 88 32.84 (27.42–38.62) 106 40.46 (34.65–46.48)
Diet quality (DQI-I) 259 39.00 (37.00–41.00) 246 39.00 (37.00–41.00)
Physical activity
Little physical activity (IPAQ) 256 250
Moderate/Intensive * 138 52.08 (46.07–58.04) 137 52.29 (46.24–58.29)
Low (<600 MET.min/week) * 127 47.92 (41.96–53.93) 175 47.71 (46.71–53.76)
Sedentary lifestyle (≥6 h/week sat down) (Yes) * 149 43.57 (38.38–48.86) 138 42.86 (37.54–48.31)
Smoking habit
≥1 cigarette/day (Yes) * 103 38.85 (32.89–44.51) 85 32.57 (27.10–38.42)
Quality of life
VAS (EuroQol-5D5L) 261 70.00 (60.00–80.00) 260 70.00 (60.00–80.00)
n: absolute value; med.: median; IQR: interquartile range; %: percentage; CI: confidence interval; HbA1c: glycosylated hemoglobin; MEDAS:
Mediterranean diet adherence questionnaire; DQI-I: international diet quality index; IPAQ: international physical activity questionnaire;
VAS: visual analogue scale of the EuroQol-5D5L quality of life questionnaire. * expressed as % (95% CI); P: statistical significance.
The changes in HbA1c after the EIRA intervention can be graphically viewed in the
violin graph (Figure 2).
Imputation and a multivariate analysis were carried out according to the protocol.
Imputation firstly took place with five imputations on all five branches, and convergence
was visually revised. Suitable regression models were selected for each outcome variable
and outcomes were combined. The effectiveness of the intervention after the ITT analysis
by applying the multilevel mixed models was adjusted by basal values and PHCCs and is
found in Table 3. The complete cases analysis appears in File S2 Table S3.
The EIRA intervention only gave statistically significant results and showed a 0.45-
point higher adherence to Mediterranean diet (95% CI: 0.01–0.89). The patients in the IG
more correctly (1.62-fold) adhered to Mediterranean diet (95% CI: 1.03–2.54) than those in
the CG.
To calculate its effect size, we converted standardized β weights (adjusted mean
difference) from the multiple regression analysis to r [59], where r was 0.51, which is a large
effect size.
The visual inspection of the model’s residue, identified for each outcome variable,
revealed neither homoscedasticity nor deviations from normality.
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Table 3. Adjusted effectiveness of the intervention in patients with DM. Results by ITT (n = 694).
Variables Adjusted MeanDifference OR 95% CI p
HbA1c (%) −0.09 −0.29–0.10 0.327 NS
Regular/good glycemia control (Yes) 0.57 0.25–1.31 0.170 NS
Diet quality (DQI-I) 0.25 −0.32–0.82 0.392 NS
Adhering to Mediterranean diet (MEDAS) 0.45 0.01–0.89 0.043 *
Good adherence to Mediterranean diet (Yes) 1.62 1.03–2.54 0.036 *
Moderate/intensive physical activity (Yes) 1.09 0.64–1.86 0.740 NS
Sedentary lifestyle (No) 0.97 0.55–1.73 0.922 NS
Smoke ≥1 cigarette/day (No) 0.61 0.54–1.06 0.079 NS
VAS (EuroQol-5D5L) −1.26 −4.98–2.45 0.504 NS
NS: p > 0.05; * p < 0.05. CI: confidence interval; HbA1c: glycosylated hemoglobin; %: percentage; MEDAS: questionnaire of adherence to the
Mediterranean diet; DQI-I: international diet quality index; VAS: scale visual analogue of the EuroQol-5D5L quality of life questionnaire;
P: statistical significance.
4. Discussion
No statistically significant changes were found for either glycemic control or physi-
cal activity, nor for sedentary lifestyle, smoking and quality of life. The multicomponent
intervention only showed a statistically significant improvement in adhering to the Mediter-
ranean diet.
The main objective of the EIRA intervention was to evaluate the effectiveness in
improving the DM population’s glycemic control. However, no statistically significant
improvements were achieved in improving glycemic control, as measured by glycated
hemoglobin, because it lowered by only 0.09%. Evidently, the better glycemic control
is prior to intervention, the more difficult it is to achieve significant improvements [49].
In our study, half the patients’ glycemic control was below <8% before the intervention
started. Nevertheless, we observed a higher probability of achieving glycemic control
below 8% (OR = 0.57) compared to another similar study (OR = 0.20) that also performed
an educational multicomponent intervention with DM patients with 7%–9% HbA1cf [60].
That study achieved significant post-intervention improvements, mostly because it began
with higher former glycated hemoglobin figures which, therefore, allowed for a wider
improvement margin. Likewise, a recent meta-analysis published in 2019 [61], which aimed
to assess the effect of Mediterranean diet on improving glycated hemoglobin, demonstrated
that it generally lowered by 1%. Adhering to Mediterranean diet for more than 12 months
would very likely give lead to biochemical significance. Hence, there is a need to include
interventions that provide evidence in day-to-day clinical practice. If not, they run the risk
of fading away with time [62].
The main finding with the Mediterranean diet was demonstrating a statistically
significant improvement in DM patients adhering to Mediterranean diet. Regarding the
clinical impact of these results, the effect size obtained indicates that this is also a clinically
relevant result, according to Cohen’s cut-offs in educational research [63].
The specific objective of MEDAS was to improvement shown by 0.45 points and
the DQI index of 0.25 compared to the initial values. These improvements were also
observed in a similar intervention for 12 months, but with a selected population of DM
patients (1.7 and 1.3, respectively) [64]. Perhaps performing an intervention with a given
population group covers more specific aspects of interest than interventions with bigger
and more diverse population groups. This and other studies [65], including the present
one, demonstrate that this type of intervention has a clinical impact on patients acquiring
healthy eating habits. It can be applied to health services and presents excellent cost
effectiveness because it is a simple intervention, PC staff are perfectly qualified to perform
it and it incurs no additional costs.
The results obtained for physical activity were not statistically significant for the seden-
tary lifestyle and IPAQ scale values. For physical activity, lack of observed effectiveness
matches the statement by Hamilton et al. about patients with diabetes being more reluctant
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to perform moderate/high physical activity compared to people with no chronic disease,
and for whom DM patients tend to spend most of the day performing activities generally
typical of a sedentary lifestyle [66].
In relation to smoking, despite the intervention managing to lower the number of
smokers, the results were not statistically significant. Although most DM patients did
not smoke before the intervention started, our findings coincide with those published in
the review by Ebrahim et al., where multicomponent interventions did not show better
smoking cessation success than classic approaches that are more individual and performed
during consultations [67].
DM patients’ quality of life did not significantly improve after the intervention. How-
ever, the final evaluation was positive with an EVA of 70 (med.) out of 100. Compared to
previous works in the literature, some studies report significant improvements in quality
of life, but they applied interventions that specifically addressed a study population with
type 2 DM [68].
As set out in the WHO’s “Global Strategy On Diet, Physical Activity and Health” [69]
for diabetes, actions must center on population measures that promote healthy habits to
lower this growing disease burden worldwide by taking different approaches (individual,
group, community). This was our approach and, yet, several factors might have contributed
to our results not being as effective as expected. A clinical trial [33] addresses individual,
group and community interventions in patients with various risks or life habits. This
means that our EIRA intervention was designed for people whose life habits could improve,
and not specifically for patients with DM. The present study analyzed the effect of this
multicomponent intervention on a single population group: patients with DM. Perhaps
the general approach based on comorbidity and many life habits and patients with DM
being selected in line with them made the intervention less effective for these patients than
other more specific interventions in our setting [70,71] and in other different socio-cultural
contexts [72,73], which could have impacted poorer results than the overall clinical trial
sample overall.
The effectiveness of the IPAQ measuring instrument is acceptable when employed in
population studies [74]. However, the literature warns about its limitations for measuring
physical activity over long periods of time and recommends using accelerometry whenever
possible [75]. However, this was not possible in our study for logistic reasons.
Other factors could explain the EIRA intervention’s lack of effectiveness overall. One
such factor is the age of our participants, from 45 to 75 years. Heltberg et al. performed
a multivariate causal study that concluded that being aged 40–65 years was related to a
higher probability of not fulfilling DM care objectives [76]. Similarly, not acting on social-
type external factors, like lack of space to facilitate acquiring conducts to promote health,
could have an impact [77].
4.1. Strengths and Limitations
The simultaneous inclusion of individual, group and community (multicomponent
intervention) components to deal with several life habits make this study innovative in the
health-promotion field with DM patients.
The fact that barely any evidence exists for the effectiveness of such interventions with
DM might be due to the complexity involved in developing and implanting them. It is true
that interventions are habitually made with DM on different life habits simultaneously,
but prescribing community resources is usually not contemplated. By including this
component in our intervention, we evidence its effectiveness in attending to DM patients.
We also stress the large number of DM patients who were analyzed, more than expected,
as explained by the high DM prevalence for people with two risk factors or more [1,2].
In order to ensure the study’s internal validity, systematized notebooks were used
to collect data. Health care professionals were trained in motivational interviews and
the intervention’s different components. Group activities were organized with the same
structure as with all the PHCCs, and community resources were mapped following the
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same methodology [39]. However, as the participants and professionals performing the
EIRA intervention were not blinded, all the participants could have changed their conduct
because they knew that they were being observed.
The flow diagram includes information about the number of participants who dropped
out of the study in each phase and their reasons for doing so (see File S2 Table S2). Fi-
nal losses were 22.19%, which did not exceed the initially foreseen 30%, and losses were
practically the same for both groups. High losses during EIRA intervention are a com-
monplace problem in such studies, and attempts are made to minimize them by reference
professionals following up on each participant and including an external support unit to
collect data.
In order to foresee this inconvenience, analyses were conducted following the ITT
principle, according to which all the subjects randomly assigned to any experimental
conditions are included in the analyses, regardless of them not adhering well to the
intervention, having dropped out of the study or for any other circumstance that could
have taken place after randomization.
The literature also warns that initial imbalances and confounding biases can arise
in cluster analyses. We considered this aspect, which led to the multilevel mixed model
analysis and the inclusion of auxiliary variables in the imputation, and this was why
random forest imputation was followed to avoid collinearity.
The analysis of the baseline values showed no major differences between both groups.
It was estimated that for properly performed simple randomization, the probability of
a factor showing a 5% statistically significant imbalance would be 5% regardless of the
sample size. Therefore, comparisons made using statistical testing are not recommended
in the CONSORT guide [34]. According to this guide, the decision to adjust must not
be determined by the initial differences being statistically significant, but rather by the
previous hypothesis of their strong influence on the result.
BMI or psychosocial support could have been unknown confounding factors, or
were not included in the statistical analysis, and could have influenced the effectiveness
of the intervention for DM patients. However, other variables, such as ethnic origin or
DM duration/seriousness, were not included because EIRA does not specifically address
DM patients.
Implementation was complex because it meant having to change work routines that
have been ongoing for years. This led to certain organizational problems, which could ex-
plain the poor adherence to group and community activities. Moreover, 61% of community
activities were not free.
Thus, despite this EIRA intervention being designed as “multicomponent”, according
to the participation results we can state that it was carried out mostly by individual
and group approaches. This could have been facilitated by the health centers in which
PC in Spain is organized, which are physical spaces where a relatively large number of
professionals work together and attend to the general public in their area. The disadvantage
lies in innovative initiatives not being well accepted by a sufficiently large part of the team
when the probability of their implementation not offering guarantees or being of worse
quality is higher.
Another main limitation is the need to individualize the EIRA intervention according
to DM patients’ intrinsic and extrinsic characteristics [1,2]. Our study took this aspect
into account, but its more general characteristics (components, duration, intensity) were
standardized to be able to analyze health outcomes, which were obtained as homoge-
neously and reproducibly as possible. Moreover, the EIRA intervention does not specif-
ically address DM patients, which is why this article included a secondary analysis of a
population subgroup.
4.2. Implications for Research and Practice
Our study’s external validity is backed by the origin of the patients included in it, who
belonged to 26 health centers from all over Spain and different social settings.
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Multicomponent interventions that address several unhealthy life habits still need to
be further investigated to evidence the effectiveness of this non-pharmacological approach
to improve glycemic control, adhere to the Mediterranean diet, practice physical exercise,
stop smoking and increase quality of life with DM. This study stresses the need to involve
PC in research to improve setting up interventions to promote health.
Regarding future lines of study, physical activity and sedentary lifestyle measures
should be refined given their impact on health. The fact that no international consensus
exists about how to measure physical activity in PC is stressed, and although several vali-
dated questionnaires exist with different characteristics and their strengths and limitations,
further evidence is lacking to definitively recommend some more than others [78].
Our study, like other similar ones, analyzes interventions about life habits. Above
all, these studies basically evidence the need for organizational changes and their routine
inclusion in PC as an offer of integrated services with the community’s co-participation,
where implementation strategies will be absolutely necessary.
Set work dynamics and organizations, which are barely flexible to organizational
changes, make their generalized implementation difficult. Proof of marked effectiveness
for these types of interventions would support them being applied to clinical practice.
It is important to point out that the EIRA study marked a before and an after in the
participating health centers. Carrying out this innovative research was well accepted by
many professionals and health managers, which facilitated its implementation in the usual
practice of group and community activities in many health centers where, until that time, it
had not been offered.
It is also worth highlighting that to successfully perform multicomponent interven-
tions, it is necessary to seek alliances with other community stakeholders. Even though
extending the network of community support is a strong point for non-pharmacological
DM treatment, it poses many organizational difficulties that need to be consolidated in the
long term.
As for evaluating such interventions, interest shown in the methods set out in the
public health field is ever-growing. Recently, Cassetti and Paredes-Carbonell proposed
a new conceptual model to explain how these interventions work, where their different
components must be identified and what the interaction between each one is like, especially
if we consider all the external factors that can influence its development [79].
5. Conclusions
The EIRA intervention carried out to promote health by adopting healthy life habits
did not significantly improve DM patients’ glycemic control.
Regarding life habits, this intervention significantly improved DM patients adhering
to Mediterranean diet but did not obtain significant results for increasing physical activity
or for reducing smoking.
DM patients’ quality of life did not significantly change with the EIRA intervention.
Such innovative interventions need further investigation to demonstrate their more
long-term effectiveness, also in specific population groups. Moreover, they need implemen-
tation strategies from health administrations/organizations to putting them into clinical
and community practice, including the analysis of their applicability to different contexts
and population groups in PC.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/ijerph18115788/s1. File S1: Independent variables, File S2: Primary healthcare centers,
recruitment and follow-up of the protocol and adjusted effectiveness of the intervention for complete
cases, File S3: Lifestyle, clinical values, pharmacological treatment, comorbidity, quality of life and
psychosocial evaluation.
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